213 related articles for article (PubMed ID: 11115072)
1. Vascular endothelial growth factor accelerates renal recovery in experimental thrombotic microangiopathy.
Kim YG; Suga SI; Kang DH; Jefferson JA; Mazzali M; Gordon KL; Matsui K; Breiteneder-Geleff S; Shankland SJ; Hughes J; Kerjaschki D; Schreiner GF; Johnson RJ
Kidney Int; 2000 Dec; 58(6):2390-9. PubMed ID: 11115072
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factor (VEGF121) protects rats from renal infarction in thrombotic microangiopathy.
Suga S; Kim YG; Joly A; Puchacz E; Kang DH; Jefferson JA; Abraham JA; Hughes J; Johnson RJ; Schreiner GF
Kidney Int; 2001 Oct; 60(4):1297-308. PubMed ID: 11576344
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritis.
Masuda Y; Shimizu A; Mori T; Ishiwata T; Kitamura H; Ohashi R; Ishizaki M; Asano G; Sugisaki Y; Yamanaka N
Am J Pathol; 2001 Aug; 159(2):599-608. PubMed ID: 11485918
[TBL] [Abstract][Full Text] [Related]
4. Impaired angiogenesis in the aging kidney: vascular endothelial growth factor and thrombospondin-1 in renal disease.
Kang DH; Anderson S; Kim YG; Mazzalli M; Suga S; Jefferson JA; Gordon KL; Oyama TT; Hughes J; Hugo C; Kerjaschki D; Schreiner GF; Johnson RJ
Am J Kidney Dis; 2001 Mar; 37(3):601-11. PubMed ID: 11228186
[TBL] [Abstract][Full Text] [Related]
5. VEGF(165) mediates glomerular endothelial repair.
Ostendorf T; Kunter U; Eitner F; Loos A; Regele H; Kerjaschki D; Henninger DD; Janjic N; Floege J
J Clin Invest; 1999 Oct; 104(7):913-23. PubMed ID: 10510332
[TBL] [Abstract][Full Text] [Related]
6. Everolimus inhibits glomerular endothelial cell proliferation and VEGF, but not long-term recovery in experimental thrombotic microangiopathy.
Keller K; Daniel C; Schöcklmann H; Endlich KH; Kerjaschki D; Johnson RJ; Hugo C
Nephrol Dial Transplant; 2006 Oct; 21(10):2724-35. PubMed ID: 16861242
[TBL] [Abstract][Full Text] [Related]
7. Impaired angiogenesis in the remnant kidney model: II. Vascular endothelial growth factor administration reduces renal fibrosis and stabilizes renal function.
Kang DH; Hughes J; Mazzali M; Schreiner GF; Johnson RJ
J Am Soc Nephrol; 2001 Jul; 12(7):1448-1457. PubMed ID: 11423573
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide modulates vascular disease in the remnant kidney model.
Kang DH; Nakagawa T; Feng L; Johnson RJ
Am J Pathol; 2002 Jul; 161(1):239-48. PubMed ID: 12107108
[TBL] [Abstract][Full Text] [Related]
9. Neutralizing TGF-beta1 antibody infusion in neonatal rat delays in vivo glomerular capillary formation 1.
Liu A; Dardik A; Ballermann BJ
Kidney Int; 1999 Oct; 56(4):1334-48. PubMed ID: 10504486
[TBL] [Abstract][Full Text] [Related]
10. Post-cyclosporine-mediated hypertension and nephropathy: amelioration by vascular endothelial growth factor.
Kang DH; Kim YG; Andoh TF; Gordon KL; Suga S; Mazzali M; Jefferson JA; Hughes J; Bennett W; Schreiner GF; Johnson RJ
Am J Physiol Renal Physiol; 2001 Apr; 280(4):F727-36. PubMed ID: 11249864
[TBL] [Abstract][Full Text] [Related]
11. A new model of renal microvascular endothelial injury.
Nangaku M; Alpers CE; Pippin J; Shankland SJ; Adler S; Kurokawa K; Couser WG; Johnson RJ
Kidney Int; 1997 Jul; 52(1):182-94. PubMed ID: 9211361
[TBL] [Abstract][Full Text] [Related]
12. Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration.
Iwaguro H; Yamaguchi J; Kalka C; Murasawa S; Masuda H; Hayashi S; Silver M; Li T; Isner JM; Asahara T
Circulation; 2002 Feb; 105(6):732-8. PubMed ID: 11839630
[TBL] [Abstract][Full Text] [Related]
13. Effects of intraventricular infusion of vascular endothelial growth factor on cerebral blood flow, edema, and infarct volume.
Harrigan MR; Ennis SR; Sullivan SE; Keep RF
Acta Neurochir (Wien); 2003 Jan; 145(1):49-53. PubMed ID: 12545262
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of renal endothelial nitric oxide synthase expression in experimental glomerular thrombotic microangiopathy.
Zhou XJ; Laszik Z; Ni Z; Wang XQ; Brackett DJ; Lerner MR; Silva FG; Vaziri ND
Lab Invest; 2000 Jul; 80(7):1079-87. PubMed ID: 10908153
[TBL] [Abstract][Full Text] [Related]
15. Infusion of angiotensin II reduces loss of glomerular capillary area in the early phase of anti-Thy-1.1 nephritis possibly via regulating angiogenesis-associated factors.
Takazawa Y; Maeshima Y; Kitayama H; Yamamoto Y; Kawachi H; Shimizu F; Matsui H; Sugiyama H; Yamasaki Y; Makino H
Kidney Int; 2005 Aug; 68(2):704-22. PubMed ID: 16014048
[TBL] [Abstract][Full Text] [Related]
16. ET(B) receptor protects the tubulointerstitium in experimental thrombotic microangiopathy.
Nangaku M; Yamada K; Gariepy CE; Miyata T; Inagi R; Kurokawa K; Yanagisawa M; Fujita T; Johnson RJ
Kidney Int; 2002 Sep; 62(3):922-8. PubMed ID: 12164874
[TBL] [Abstract][Full Text] [Related]
17. Renal ischemia-reperfusion increases endothelial VEGFR-2 without increasing VEGF or VEGFR-1 expression.
Kanellis J; Paizis K; Cox AJ; Stacker SA; Gilbert RE; Cooper ME; Power DA
Kidney Int; 2002 May; 61(5):1696-706. PubMed ID: 11967019
[TBL] [Abstract][Full Text] [Related]
18. Loss of the VEGF(164) and VEGF(188) isoforms impairs postnatal glomerular angiogenesis and renal arteriogenesis in mice.
Mattot V; Moons L; Lupu F; Chernavvsky D; Gómez RA; Collen D; Carmeliet P
J Am Soc Nephrol; 2002 Jun; 13(6):1548-60. PubMed ID: 12039984
[TBL] [Abstract][Full Text] [Related]
19. Synergistic effect of hyaluronan oligosaccharides and vascular endothelial growth factor on angiogenesis in vitro.
Montesano R; Kumar S; Orci L; Pepper MS
Lab Invest; 1996 Aug; 75(2):249-62. PubMed ID: 8765325
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor165 resolves glomerular inflammation and accelerates glomerular capillary repair in rat anti-glomerular basement membrane glomerulonephritis.
Shimizu A; Masuda Y; Mori T; Kitamura H; Ishizaki M; Sugisaki Y; Fukuda Y
J Am Soc Nephrol; 2004 Oct; 15(10):2655-65. PubMed ID: 15466270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
